Drug
Varivax New Seed Process
Varivax New Seed Process: highest development phase Phase 3, developed by Merck. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Merck
Trials
| Drug | Phase | Indication |
|---|---|---|
| VARIVAX™ New Seed Process NCT02062502 | Phase 3 | Varicella |
Latest
No recent events.
Follow Varivax New Seed Process on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.